A Phase III Trial For Patients With Metastatic Breast Cancer

NCT00191152 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

475

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Breast Neoplasms
Cancer of the Breast

Interventions

DRUG: gemcitabine
DRUG: docetaxel
DRUG: capecitabine

Sponsor

Eli Lilly and Company